US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Ongoing

Aloe Gator

Reason Out of Specification for active ingredient

ARG Laboratories, Inc. D-0530-2024
Class II · Moderate risk Ongoing

Natural Pain Relieving Cream

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0529-2024
Class II · Moderate risk Ongoing

Pain Wizard

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0528-2024
Class II · Moderate risk Ongoing

Natural Pain Relieving Cream

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0527-2024
Class II · Moderate risk Ongoing

Natural Pain Relieving Cream

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0526-2024
Class II · Moderate risk Ongoing

Pain Wizard

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0525-2024
Class II · Moderate risk Ongoing

Pain Wizard

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0524-2024
Class II · Moderate risk Ongoing

Aloe Gator

Reason Out of Specification for active ingredient

ARG Laboratories, Inc. D-0523-2024
Class II · Moderate risk Ongoing

Natural Pain Relieving Cream

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0521-2024
Class II · Moderate risk Ongoing

Pain Wizard

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0520-2024
Class II · Moderate risk Completed

Gordofilm Wart Remover

Reason cGMP Deviations

Dercher Enterprises, Inc., DBA Gordon Laboratories NDC 10481-3009-01 D-0495-2024
Class III · Low risk Ongoing

Abilify

Reason Cross Contamination with Other Products

Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. NDC 59148-011-13 D-0469-2024
Class III · Low risk Ongoing

Abilify

Reason Cross Contamination with Other Products

Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. NDC 59148-009-13 D-0468-2024
Class III · Low risk Ongoing

Abilify

Reason Cross Contamination with Other Products

Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. NDC 59148-008-13 D-0467-2024
Class III · Low risk Ongoing

Abilify

Reason Cross Contamination with Other Products

Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. NDC 59148-007-13 D-0466-2024
Class I · High risk Ongoing

Javygtor

Reason Sub-potent Drug; powder discoloration associated with decreased potency

Dr. Reddy's Laboratories, Inc. NDC 43598-097-30 D-0485-2024
Class III · Low risk Terminated

Cyclophosphamide for Injection

Reason Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

X-Gen Pharmaceuticals Inc. NDC 39822-0255-01 D-0434-2024
Class III · Low risk Terminated

Cyclophosphamide for Injection

Reason Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

X-Gen Pharmaceuticals Inc. NDC 39822-0250-01 D-0433-2024
Class II · Moderate risk Terminated

Eyesaline

Reason CGMP Deviations

Honeywell INC D-0461-2024
Class I · High risk Terminated

Atovaquone Oral Suspension USP

Reason Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.

AvKARE NDC 50268-086-12 D-0444-2024